carbon
anhydras
ca
famili
zinc
metalloenzym
catalyz
revers
hydrat
carbon
dioxid
order
maintain
ph
balanc
live
organ
caix
transmembran
glycoprotein
molecular
weight
structur
caix
consist
four
domain
ntermin
proteoglycanlik
domain
pg
aa
ca
catalyt
domain
ca
aa
transmembran
helic
segment
aa
short
intracytoplasm
tail
aa
hypox
condit
caix
gene
directli
activ
transcript
level
hypoxia
induc
transcript
factor
lead
transport
proton
extracellular
medium
lower
thu
caix
express
regard
surrog
marker
hypoxia
variou
result
acidif
tumor
microenviron
ca
activ
keratin
sulfat
unit
olink
glycan
structur
pg
domain
caix
presum
play
import
role
process
cell
adhes
tumor
caix
consid
tumorassoci
antigen
overexpress
found
among
sever
solid
tumor
type
particularli
clear
cell
type
renal
cell
carcinoma
rcc
well
carcinoma
sever
histolog
type
includ
ovarian
breast
esophag
bladder
colon
nonsmal
cell
lung
dysplasia
cervix
caix
express
suggest
serv
marker
cancer
diagnosi
earli
detect
also
prognost
marker
favor
respons
interleukin
il
patient
melanoma
kidney
cancer
lead
high
respons
rate
low
immunostain
western
blot
studi
shown
high
level
caix
express
restrict
major
primari
rcc
clear
cell
type
granular
spindl
cell
papillari
type
chromophil
cell
collect
duct
except
chromphob
cell
cystic
rcc
metastat
rcc
observ
normal
kidney
tissu
benign
epitheli
cystic
lesion
nonren
cell
clear
cell
rcc
one
two
immunogen
tumor
type
besid
melanoma
exhibit
evid
spontan
regress
metastat
lesion
respons
immunomodul
therapi
cancer
vaccin
adopt
cell
therapi
metastat
melanoma
rcc
patient
use
ex
vivo
expand
tumorinfiltr
lymphocyt
shown
recent
tcell
receptor
tcr
modifi
cell
chain
also
use
provid
effect
tumor
target
tcell
howev
posttarget
antitumor
activ
hamper
defici
involv
downregul
level
major
histocompat
complex
class
irestrict
antigen
present
induc
anergi
due
loss
express
costimulatori
molecul
well
shed
molecul
secret
cytokin
immunosuppress
activ
chimer
antigen
receptor
car
design
consist
singlechain
antibodi
scfv
coupl
signal
modul
tcr
complex
express
car
cell
cart
cell
enabl
redirect
cell
preselect
tumor
antigen
major
histocompat
complexindepend
antibodytyp
recognit
potent
tcr
cytotox
one
exampl
murin
recogn
pg
domain
caix
use
construct
firstgener
singlechain
antibodi
chimer
receptor
scfv
retroviru
transduc
express
autolog
cell
adopt
immunotherapi
conjunct
lowdos
treatment
three
metastat
rcc
patient
howev
two
three
patient
suffer
liver
toxic
necessit
lower
cart
dose
pretreat
caix
monoclon
antibodi
prevent
liver
thu
improv
safeti
efficaci
requir
cellular
therapi
rcc
move
clinic
trial
recent
focu
car
design
shift
incorpor
endodomain
cell
costimulatori
molecul
overcom
problem
ineffici
effector
function
anerg
statu
antitumor
cart
cell
incorpor
costimulatori
molecul
car
gener
cart
cell
superior
antitumor
activ
includ
tumorinduc
prolifer
cytotox
cytokin
secret
clonal
expans
tumor
regress
anim
tumor
model
two
encourag
preclin
find
establish
advantag
cart
therapi
tradit
adopt
cell
therapi
first
inject
cart
cell
requir
littl
week
tumor
regressionerad
metastist
without
establish
tumor
mice
second
vivo
persist
cart
cell
host
treatment
strong
antitumor
activ
maxim
cart
cell
incorpor
costimulatori
molecul
could
detect
least
month
mous
bear
human
preb
acut
lymphoblast
leukemia
addit
recent
clinic
trial
complet
remiss
longterm
surviv
effector
memori
cell
observ
two
three
patient
advanc
chemotherapyresist
chronic
lymphocyt
leukemia
cll
receiv
adopt
immunotherapi
use
secondgener
car
target
illustr
success
translat
therapeut
similarli
secondgener
car
target
shown
promis
result
cll
indol
bcell
lymphoma
character
antibodydepend
cellular
cytotox
adcc
five
caixspecif
scfv
antibodi
isol
human
phage
display
librari
lead
scfv
chosen
incorpor
two
car
construct
firstgener
secondgener
compar
vitro
antitumor
respons
two
type
cart
cell
show
superior
cart
cell
multipl
paramet
conjunct
highdos
inject
cart
cell
show
mark
tumor
regress
nude
mice
bear
subcutan
establish
caix
rcc
addit
situ
distribut
cart
cell
within
tumor
mice
provid
evid
enhanc
antitumor
activ
previous
report
panel
highaffin
human
anticaix
antibodi
differ
epitop
map
express
level
abil
intern
first
aim
investig
antitumor
activ
five
anticaix
singlechain
antibodi
candid
car
construct
test
anticaix
mabmedi
adcc
scfv
convert
scfvfc
found
scfvfc
exhibit
antigenspecif
tumor
lysi
tumor
cell
line
high
caix
express
specif
lysi
rang
moder
caix
express
specif
lysi
rang
background
lysi
tumor
cell
line
neg
control
scfvfc
antisar
background
level
cell
lysi
seen
figur
base
adcc
kill
publish
analys
chosen
evalu
cartarget
moieti
two
gener
anticaix
car
construct
firstgener
car
link
truncat
extracellular
hing
transmembran
domain
plu
signal
domain
deliv
costimulatori
signal
secondgener
car
gener
consist
fuse
truncat
extracellular
transmembran
intracellular
domain
plu
signal
domain
figur
irrelev
secondgener
car
made
use
antihiv
clone
order
detect
express
construct
human
rhodopsin
tag
insert
scfv
domain
respect
zsgreen
express
ire
sequenc
high
concentr
viral
stock
obtain
compar
level
among
differ
construct
test
cotransfect
vector
plasmid
cell
data
shown
transduct
pha
mitogen
use
stimul
peripher
blood
lymphocyt
day
concentr
lentiviru
supernat
use
infect
human
primari
cell
presenc
cation
reagent
diethylaminoethyldextran
deaedextran
increas
transduct
rate
compar
polybren
data
shown
transduct
rate
primari
cell
rang
zsgreen
express
fluorescenceactiv
cell
sort
fac
analysi
repres
experi
show
zsgreen
express
circa
primari
cart
cell
follow
lentiviru
transduct
shown
figur
left
column
caixfc
fusion
protein
bind
cart
cell
control
cart
cell
figur
middl
column
express
detect
circa
onethird
level
caixfc
protein
figur
right
column
like
relat
find
mab
preferenti
recogn
rhodopsin
nonapeptid
present
carboxytermin
versu
intern
polypeptid
sequenc
data
shown
transduc
cell
cultur
vitro
week
maintain
express
zsgreen
western
blot
reduc
condit
car
migrat
molecular
weight
circa
wherea
endogen
kda
car
migrat
molecular
weight
circa
kd
nonreduc
condit
two
car
form
homodim
figur
data
car
shown
studi
perform
compar
report
superior
effect
use
secondgener
cart
cell
incorpor
signal
compon
costimulatori
molecul
bypass
major
histocompat
complex
present
enhanc
cell
effector
function
versu
firstgener
cart
cell
seen
figur
incub
caix
cell
overnight
low
level
type
cytokin
interferon
ifn
secret
seen
control
cart
cell
lak
cell
alon
contrast
first
secondgener
express
cart
cell
show
elev
level
cytokin
secret
secondgener
cart
cell
secret
higher
amount
type
cytokin
reflect
higher
activ
statu
compar
firstgener
cart
cell
specif
cart
cell
secret
respect
cart
cell
specif
cytokin
secret
induct
two
cart
cell
seen
minim
stimul
cell
elispot
studi
interact
caix
tumor
cart
cell
becam
highcapac
produc
cell
figur
cart
cell
produc
time
spot
seen
cart
cell
upon
interact
caix
skrc
tumor
cell
time
spot
seen
interact
tumor
cell
similarli
cart
cell
higher
amount
granzym
bsecret
spot
contact
caix
tumor
compar
cart
cell
control
cell
pma
ionomycin
stimul
cell
yield
highest
amount
granzym
b
secret
cell
studi
demonstr
specif
high
capac
cart
cell
activ
contact
caix
tumor
cell
vitro
cytotox
assay
establish
evalu
kill
activ
differ
cart
cell
use
differ
ratio
effectortotarget
cart
cell
twice
vivo
passag
subclon
exhibit
highest
amount
cytolysi
caix
tumor
figur
high
ratio
cart
cell
show
two
threefold
higher
cytotox
cart
cell
low
ratio
cart
cell
show
eight
ninefold
higher
lysi
cart
cell
howev
cart
cell
still
exhibit
good
cytotox
tumor
lysi
use
e
ratio
irrelev
cart
cell
control
cell
lak
show
background
nonspecif
tumor
lysi
around
lysi
use
highest
e
ratio
case
use
tumor
transduc
untransduc
cell
show
background
lysi
besid
enhanc
cytokin
secret
cytotox
shortterm
caix
tumor
cell
contact
incorpor
costimulatori
molecul
car
construct
demonstr
improv
prolifer
upon
prolong
contact
antigenspecif
tumor
cell
untransduc
transduc
around
cell
mix
freshli
irradi
tumor
cell
weekli
presenc
unitsml
human
test
differ
level
antigen
stimul
fix
amount
cell
use
tumor
cell
cell
ratio
cell
number
count
trypan
exclus
cart
cell
fraction
examin
flow
cytometri
cultur
tumor
cell
number
transduc
untransduc
cell
maintain
figur
right
panel
lack
basal
level
prolifer
control
cell
might
due
high
amount
suppress
cytokin
secret
tumor
cell
line
contrast
week
cultur
caix
tumor
cell
ratio
popul
cart
cell
increas
cart
cell
prolifer
wherea
ratio
number
cart
cell
increas
cart
cell
prolifer
higher
amount
tumor
cell
neither
cart
cell
could
prolifer
irrelev
cart
cell
control
cell
lak
show
prolifer
tumor
cell
figur
left
panel
prolifer
cell
also
harvest
examin
enrich
caix
tumor
cell
contact
tumor
contact
chang
percentag
cart
cell
within
popul
howev
contact
caix
tumor
cell
enrich
popul
cart
cell
cart
cell
posit
popul
enrich
day
day
day
express
cart
cell
enrich
day
level
cell
day
day
expans
cart
cell
seen
studi
figur
percentag
cell
remain
constant
throughout
studi
condit
figur
transduc
cell
contact
irradi
tumor
cell
week
also
test
cytokin
secret
hour
contact
fresh
nonirradi
tumor
cell
upon
contact
caix
tumor
week
cart
cell
show
similar
secret
level
although
costimulatori
signal
car
yield
secret
seen
car
tabl
secret
week
tumor
contact
cart
cell
exhibit
secret
week
contact
cart
cell
yield
cart
cell
week
contact
contact
week
addit
cart
cell
contact
tumor
cell
week
secret
one
time
tumor
contact
wherea
cart
gave
secret
week
compar
week
tumor
contact
result
indic
transduc
cart
cell
becom
exhaust
maintain
function
activ
second
tumor
stimul
background
level
secret
seen
lak
cart
cell
treatment
contact
cell
next
test
cart
cell
abil
inhibit
establish
tumor
cell
growth
nude
mice
inocul
tumor
cell
left
flank
tumor
cell
right
flank
establish
yield
similar
tumor
curv
day
tumor
implant
typic
tumor
size
mm
million
cart
cell
cart
cell
untransduc
cell
lak
inject
intraven
adopt
tcell
therapi
perform
two
separ
experi
group
size
n
first
trial
n
second
trial
presenc
highdos
iu
via
intraperiton
inject
tcell
treatment
includ
order
compar
growth
tumor
effect
celltherapi
trial
one
treat
untreat
tumor
averag
size
mm
day
mm
day
within
four
test
group
exhibit
tumor
growth
rate
control
group
tcelltreat
group
untreat
caix
tumor
receiv
cell
show
similar
tumor
size
tumor
averag
size
mm
day
mm
day
howev
tumor
size
cart
celltreat
mice
show
statist
signific
reduct
size
compar
tcelltreat
mice
everi
time
point
examin
studi
figur
cart
treatment
also
led
greater
reduct
tumor
size
seen
cart
cell
laktreat
mice
day
p
day
p
calcul
twotail
ttest
trial
two
tumor
size
cart
celltreat
mice
signific
smaller
tcelltreat
mice
experi
cart
celltreat
mice
also
smaller
tumor
seen
cart
cell
laktreat
mice
day
day
p
day
p
figur
partial
regress
caix
tumor
consid
tumor
size
smaller
volum
control
tumor
mous
receiv
tcell
treatment
partial
tumor
regress
observ
high
percentag
case
use
cart
cell
infrequ
irrelev
target
cart
cell
activ
cell
lak
tabl
frequenc
partial
regress
respons
found
statist
signific
mice
treat
cart
cell
versu
control
cart
cell
lak
p
p
respect
fisher
test
sampl
whole
popul
transduc
cell
use
vivo
studi
prestain
far
red
dye
cart
cell
express
zsgreen
protein
within
popul
analyz
confoc
microscopi
result
demonstr
circa
transduct
effici
agreement
fac
analysi
figur
provid
evid
cart
cell
treatment
caix
tumor
cell
vivo
result
kill
apoptosi
tumor
section
stain
tunnel
assay
day
adopt
cell
treatment
tunnel
stain
identifi
apoptot
tumor
cell
red
edg
tumor
figur
upper
row
insid
tumor
bed
figur
middl
row
apopto
tumor
cell
lost
dapi
nuclear
stain
shown
enlarg
graph
figur
bottom
row
zsgreen
express
cart
cell
interact
two
tumor
cell
go
apoptosi
due
limit
fluoresc
signal
zsgreen
express
cart
cell
could
observ
whole
tissu
section
therefor
day
cart
cell
lak
treatment
tumor
harvest
section
also
stain
granzym
b
antibodi
locat
activ
cell
figur
dark
brown
area
stain
show
granzym
b
cell
seen
infiltr
caix
tumor
section
figur
upper
left
granzym
b
cell
seen
surround
tumor
figur
upper
left
middl
insid
tumor
figur
upper
left
b
lower
tumor
necrot
area
shown
h
e
stain
slide
label
n
insid
figur
right
middl
lower
lie
locat
near
granzym
b
cell
contrast
caix
tumor
treat
control
activ
cell
lak
supplementari
figur
show
granzym
b
cell
similarli
treat
cart
cell
supplementari
figur
treat
lak
supplementari
figur
show
lowbackground
stain
tumor
prolifer
posit
control
granzym
b
stain
cart
cell
local
inject
establish
tumor
mice
day
mice
sacrif
tumor
tissu
section
stain
supplementari
figur
studi
character
panel
five
human
scfvfc
catalyt
domain
carbon
anhydras
caix
adcc
activ
anticaix
mab
show
potent
adcc
activ
suggest
caix
epitop
properli
orient
respect
plasma
membran
kill
occur
antibodi
chosen
target
anticaix
car
base
kill
activ
good
express
level
abil
mediat
caix
construct
selfinactiv
lentivir
vector
express
first
secondgener
fulli
human
car
perform
extens
vitro
comparison
two
also
first
report
vivo
antitumor
activ
cart
cell
rcc
consist
previou
report
car
contain
costimulatori
signal
motif
secondgener
cart
cell
possess
superior
effector
function
compar
firstgener
cart
cell
vitro
assay
includ
cytokin
secret
figur
cytolyt
activ
figur
c
prolifer
figur
clonal
expans
figur
shown
promot
antitumor
activ
cell
like
involv
tumorocid
activ
observ
vivo
howev
cytokin
also
implic
recruit
nk
cell
role
antitumor
immun
cytokin
may
differ
function
depend
tumor
type
secret
cell
shown
enhanc
antitumor
immun
mechanist
link
nk
activ
recent
secondgener
cart
cell
also
show
superior
activ
vivo
inhibit
caix
tumor
cell
growth
compar
irrelev
cart
lak
cell
figur
situ
studi
provid
evid
tumor
cell
apoptosi
figur
well
presenc
granzym
b
cell
tumor
necrosi
figur
greater
vivo
effector
function
mediat
cart
cell
may
due
sever
mechan
first
cart
cell
show
greater
capac
prolifer
repeat
contact
caix
tumor
cell
cart
cell
figur
show
augment
capac
secret
recontact
caix
tumor
cell
tabl
second
addit
enhanc
proinflammatori
cytokin
secret
cart
cell
may
resist
activationinduc
cell
death
result
tumor
antigen
contact
cart
receiv
tcell
receptor
signal
activationinduc
cell
death
resist
due
upregul
express
antiapoptot
protein
cflip
bclxl
cytoplasm
domain
also
serv
enhanc
cellular
activ
protein
kinas
third
cart
cell
may
better
protect
suppress
regulatori
cell
treg
inhibitori
cytokin
transform
growth
due
enhanc
activ
phosphoinositid
inde
expans
treg
found
significantli
higher
dcvaccin
cytokin
therapi
nonrespond
respond
resist
provid
extra
benefit
cart
immunotherapi
avoid
develop
unwant
immunogen
respons
follow
introduct
carspecif
antibodi
adopt
transfer
use
chimer
tcr
receptor
use
human
human
scfv
shown
scfv
compon
car
deriv
murin
monoclon
antibodi
result
detect
level
human
antimous
antibodi
hama
hama
might
inhibit
redirect
cell
function
block
interact
car
target
immunogen
car
restrict
durat
treatment
thu
limit
overal
antitumor
effect
inde
murin
anticaix
mab
use
firstgener
car
rcc
clinic
trial
antiidiotyp
antibodi
anticar
cellmedi
immun
scfv
compon
develop
neutral
result
cart
cell
addit
socal
ontarget
liver
toxic
cell
observ
attribut
caix
express
bile
duct
epitheli
inde
express
caix
normal
tissu
immunohistochem
stain
document
use
murin
anticaix
mab
direct
ntermin
pg
domain
stain
larg
restrict
apic
surfac
cell
stomach
bile
duct
small
thu
autoreact
could
either
induc
directli
anticaix
cart
cell
recogn
normal
tissu
express
target
antigen
indirectli
antibodi
cellmedi
immun
direct
anticaix
cart
cell
local
tissu
contrast
mab
recogn
central
locat
catalyt
domain
recogn
caix
immunohistochem
stain
data
shown
therefor
remain
determin
similar
crossreact
toxic
would
occur
vivo
cart
cell
howev
superior
effect
antitumor
function
secondgener
cart
cell
fulli
human
format
scfv
car
may
prefer
agent
use
futur
clinic
trial
propos
requir
lower
dose
infus
cart
cell
reduc
immunogen
due
absenc
hama
cellmedi
immun
cmi
respons
scfv
cart
cell
case
cell
surfaceexpress
tumorassoci
antigen
caix
shed
tumor
cell
surfac
blood
stream
known
whether
circul
caix
compet
cell
surfac
caix
tumor
cell
bind
cart
cell
also
anoth
potenti
complic
solubl
serum
caix
caus
widespread
trigger
infus
genet
redirect
cell
turn
might
lead
massiv
cytokin
releas
includ
fortun
sever
studi
document
solubl
serum
antigen
inhibit
cart
cell
respons
indic
result
cytokin
releas
cytotox
summari
demonstr
secondgener
cart
cell
possess
superior
antitumor
respons
evidenc
combin
effect
stronger
cytotox
potenc
increas
cytokin
secret
enhanc
prolifer
clonal
expans
vitro
improv
suppress
tumor
vivo
provis
higher
respons
rate
low
toxic
also
demonstr
patient
treat
firstgener
anticaix
cart
cell
pretreat
chimer
caix
ab
strategi
could
similarli
develop
fulli
human
anticaix
addit
costimulatori
molecul
includ
continu
assess
car
construct
order
maxim
effect
activ
modifi
opportun
may
aris
reduc
number
cell
requir
efficaci
adopt
tcell
therapi
importantli
human
cart
cell
elicit
hama
cmi
respons
treatment
cycl
envis
cart
cell
use
either
alon
togeth
agent
includ
focus
costimulatori
blockad
axi
may
provid
next
gener
treatment
rcc
human
caix
rcc
cell
line
obtain
dr
gerd
ritter
memori
sloankett
cancer
center
new
york
cultur
complet
medium
contain
rpmi
medium
life
technolog
grand
island
ny
supplement
fc
mmoll
lglutamin
uml
penicillin
streptomycin
sigma
st
loui
mo
primari
human
cell
maintain
human
serum
iuml
recombin
human
chiron
emeryvil
ca
human
embryon
kidney
cell
line
atcc
manassa
va
mous
fibroblast
cell
atcc
grown
complet
medium
life
technolog
contain
dulbecco
eagl
medium
medium
fc
uml
penicillin
streptomycin
sigma
leukopack
obtain
blood
bank
children
hospit
boston
collect
healthi
volunt
written
inform
consent
caixspecif
scfv
antibodi
isol
nonimmun
human
scfv
phage
librari
previous
report
submit
genbank
access
number
ref
scfvcode
dna
fragment
pfarber
phagemid
digest
sfiinoti
site
subclon
mammalian
express
vector
human
leader
sequenc
human
fc
portion
express
scfvfc
antibodi
plasmid
scfvfc
transient
transfect
cell
lipofectamin
invitrogen
carlsbad
ca
express
antibodi
purifi
use
sepharos
protein
bead
amersham
bioscienc
ge
healthcar
piscataway
nj
specif
bind
caix
test
stain
phage
scfv
antibodi
scfv
convert
scfvfc
format
antibodi
incub
caixexpress
cell
line
caix
neg
cell
line
experi
irrelev
antihiv
antibodi
clone
antisar
antibodi
fluoresc
conjug
secondari
antibodi
alon
use
neg
control
dna
construct
phagemid
vector
obtain
dr
michel
sadelain
memori
sloankett
cancer
center
new
york
scfv
intracellular
domain
append
n
cterminu
human
chain
respect
similarli
scfv
sequenc
append
n
cterminu
human
respect
amino
acid
sequenc
human
residu
length
consist
aa
aa
aa
residu
extracellular
hing
transmembran
cytoplasm
domain
respect
sequenc
residu
length
consist
aa
aa
aa
residu
extracellular
transmembran
cytoplasm
domain
respect
human
intracellular
domain
common
car
consist
amino
acid
aa
nucleic
acid
sequenc
encod
intern
nineamino
acid
peptid
human
rhodopsin
tetsqvapa
gggg
linker
amplifi
pcr
fuse
upstream
sequenc
noti
site
paci
site
primer
use
clone
chimer
construct
tag
ggc
gcg
gcc
gca
acc
gag
acc
agc
cag
gtg
gcg
ccc
gcc
ggg
gga
gga
ggc
agc
ccc
acc
acg
acg
cca
gcg
ccg
cga
forward
primer
construct
ital
noti
site
upper
case
tag
sequenc
underlin
indic
gggg
linker
tag
ggc
gcg
gcc
gca
acc
gag
acc
agc
cag
gtg
gcg
ccc
gcc
ggc
gga
gga
ggc
agc
att
gaa
gtt
atg
tat
cct
cct
cct
forward
primer
construct
revers
primer
construct
cta
gcc
tt
aat
taa
tta
gcg
agg
agg
ggg
cag
ggc
ctg
cat
ital
pac
site
dna
fragment
encod
function
featur
arrang
accord
follow
sequenc
noti
tetsqvqpq
gggg
paci
chimer
tcr
construct
tag
intern
peptid
clone
stuffer
vector
contain
scfvfc
clone
use
noti
paci
restrict
site
design
allow
us
insert
chimer
tcr
receptor
construct
replac
fc
portion
fragment
later
anticaix
scfv
clone
scfv
clone
irrelev
scfv
control
antibodi
fragment
clone
replac
scfv
sfiinoti
site
creat
caixspecif
chimer
tcr
construct
lentiviru
vector
phagecmvdsredireszsgreen
four
hiv
helper
plasmid
hiv
gagpol
pmdtat
prccmvrev
env
vsvg
pseudotyp
obtain
dr
richard
mulligan
viru
product
core
harvard
gene
therapi
initi
boston
cmv
promot
phagecmvireszsgreen
replac
promot
deriv
psin
lentiviru
vector
speinoti
site
one
five
scfvfc
antibodi
possess
high
affin
caix
cell
high
adcc
caix
tumor
cell
clone
lentiviru
vector
ascibamhi
replac
first
cassett
dsred
protein
lentiviru
produc
five
plasmid
transient
transfect
cell
use
lipofectamin
per
manufactur
instruct
invitrogen
cell
prepar
confluenc
cm
petri
dish
nalg
nunc
rochest
ny
transfect
total
plasmid
dna
ratio
vector
plasmid
hiv
gagpol
pmdtat
prccmvrev
env
vsvg
pseudotyp
chang
medium
viru
supernat
harvest
day
filtrat
filter
concentr
ultracentrifug
beckman
coulter
fullerton
ca
minut
rpm
g
beckman
rotor
viru
pellet
resuspend
medium
kept
frozen
human
peripher
blood
mononucl
cell
isol
ficol
densiti
gradient
separ
activ
phytohemagglutinin
pha
sigma
plu
iuml
human
day
cell
infect
two
three
round
lentiviru
transduct
multipl
infect
presenc
deaedextran
three
day
transduct
transduc
cell
collect
phenotyp
function
analys
vitro
expand
vivo
experi
transduct
effici
human
primari
cell
assess
express
report
gene
zsgreen
clontech
mountain
view
ca
caixfc
protein
express
plasmid
encod
amino
acid
caix
follow
human
hing
domain
caix
signal
peptid
aa
replac
ig
leader
sequenc
express
scfv
transduc
cell
test
stain
cell
caixfc
protein
apcconjug
mous
antihuman
igg
antibodi
jackson
immunoresearch
west
grove
pa
addit
express
intern
rhodopsin
nonapeptid
tetsqvapa
tag
scfv
domain
tcr
construct
transduc
cell
detect
stain
mous
antibodi
follow
apcconjug
goat
antimous
igg
antibodi
jackson
immunoresearch
analysi
subset
human
cell
cultur
clonal
expans
experi
stain
fluoresc
conjug
mous
antihuman
antibodi
invitrogen
clone
clone
clone
cell
stain
five
hundr
thousand
cell
stain
antibodi
recommend
concentr
accord
compani
instruct
match
isotyp
control
antibodi
sampl
use
cell
analyz
use
facscalibur
cytomet
bectondickinson
franklin
lake
nj
cytotox
assay
perform
use
delfia
eutda
cytotox
kit
perkin
elmer
boston
accord
manufactur
instruct
briefli
target
tumor
cell
label
fluoresc
ligand
batda
minut
label
cell
load
per
well
ubottom
plate
adcc
assay
panel
anticaix
scfvfc
antibodi
irrevel
scfvfc
antibodi
concentr
ad
separ
assay
set
ratio
effector
cell
human
peripher
blood
mononucl
cell
target
cell
e
cell
cytox
assay
differ
ratio
effector
cell
nontransduc
transduc
cell
target
cell
e
prepar
cultur
incub
hour
humidifi
plate
spun
minut
g
supernat
transfer
flatbottom
plate
two
hundr
microlit
europium
solut
ad
fluoresc
releas
cell
read
fluoromet
victor
perkinelm
control
spontan
releas
prepar
cultur
label
cell
control
maximum
releas
made
ad
lysi
buffer
kit
provid
label
cell
cytokin
secret
rcc
cell
line
caix
seed
overnight
per
well
plate
follow
untransduc
transduc
cell
cocultur
tumor
cell
cell
wash
phosphatebuff
salin
twice
remov
human
overnight
incub
supernat
harvest
analyz
enzymelink
immunosorb
assay
ebiosci
san
diego
ca
detect
cell
elispot
assay
ebiosci
membran
develop
use
aec
substrat
solut
number
spot
count
elispot
plate
reader
ctl
cellular
technolog
shaker
height
oh
western
blot
prepar
untransduc
transduc
cell
one
million
cell
prepar
nonreduc
reduc
buffer
moll
dithiothreitol
run
polyacrylamid
gradient
gel
invitrogen
protein
transfer
polyvinylid
fluorid
transfer
membran
nen
life
scienc
product
boston
v
overnight
membran
incub
primari
antibodi
antihuman
monoclon
antibodi
bd
pharmingen
san
diego
ca
secondari
antibodi
horseradish
peroxidas
caltag
buckingham
uk
immunodetect
perform
use
ecl
plu
western
blot
detect
system
ge
healthcar
piscataway
nj
xray
film
exposur
tumor
cell
irradi
rad
seed
per
well
cell
ad
cultur
medium
contain
plu
iuml
human
week
cultur
cell
split
maintain
suitabl
densiti
restimul
tumor
cell
weekli
number
cell
count
everi
day
week
percentag
express
zsgreen
transduc
cell
cell
subset
determin
weekli
fac
cytokin
secret
studi
tumor
cell
contact
cell
contact
irradi
tumor
cell
week
wash
incub
fresh
tumor
cell
overnight
cultur
supernat
collect
hour
analysi
due
immunereject
femal
balbc
nude
mice
acceler
vivo
growth
properti
five
million
cell
subcutan
inocul
mice
harvest
expand
vitro
cell
line
passag
two
time
nude
mice
passag
cell
expand
experi
subclon
therapeut
experi
million
million
passag
cell
subcutan
inocul
oppos
flank
nude
mice
yield
compar
tumor
growth
rate
day
tumor
grew
size
mm
million
nontransduc
transduc
cell
inject
intraven
mice
also
treat
iu
human
periton
inject
everi
day
tumor
size
measur
calip
two
dimens
mean
two
tumor
diamet
report
anim
experi
perform
accord
guidelin
dana
farber
cancer
institut
anim
care
committe
mice
sacrif
tumor
reach
diamet
tumor
harvest
vitro
examin
transduc
cell
cultur
cell
wash
twice
use
phosphatebuff
salin
resupend
far
red
ddaos
celltrac
dye
molecular
probe
life
technolog
phosphatebuff
salin
minut
cell
wash
cultur
medium
twice
cytospun
glass
slide
far
red
prestain
cart
cell
zsgreen
coexpress
visual
use
confoc
microscopi
zeiss
jena
germani
optic
imag
core
facil
harvard
neurodiscoveri
center
examin
kill
effect
transduc
cell
tumor
bed
situ
tumor
prepar
frozen
section
apoptag
peroxidas
situ
apoptosi
detect
kit
emd
millipor
billerica
cryosect
incub
tdt
enzym
millipor
hour
rabbit
antidig
dako
carpinteria
ca
ad
incub
minut
antirabbit
antibodi
invitrogen
ad
incub
minut
section
mount
dapi
antifad
mount
medium
fluoresc
imag
examin
use
confoc
microscopi
xenograft
tumor
mous
spleen
harvest
fix
formalinphosphatebuff
salin
solut
submit
harvard
medic
school
rodent
histopatholog
core
facil
paraffinembed
section
dewax
xylen
rehydr
grade
alcohol
stain
immunohistochemistri
stain
perform
incub
antihuman
granzym
b
antibodi
dako
clone
primari
antibodi
hour
follow
secondari
antirabbit
antibodi
pierc
thermoscientif
rockford
il
antimous
antibodi
dako
minut
section
develop
use
dab
substrat
counterstain
hematoxylin
statist
signific
determin
use
twotail
student
ttest
